Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  2.40 7.38% 34.90 34.00 35.00 34.75 32.50 32.75 2,048,221 16:35:13
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -7.2 -4.5 - 71

Futura Medical Share Discussion Threads

Showing 16951 to 16973 of 17850 messages
Chat Pages: Latest  690  689  688  687  686  685  684  683  682  681  680  679  Older
DateSubjectAuthorDiscuss
05/7/2019
14:44
Great time to top-up / buy in. FUM has a near term share price target of 60p and after TPR100 approval and news on MED2005 this will be £1.40+
guessing
05/7/2019
14:31
Excellent opportunity to top up at the moment, it's a win win situation now. Those selling now are looking for a quick buck whereas it's an opportunity now to improve our averages, the last 2 weeks have shown how quick this will move, the situation hasn't changed, this will rocket up close to the trial results and those holding and topping up will be the winners
tiananmen
05/7/2019
13:40
No, has very strong safety profile. Bottoms up.
j777j
05/7/2019
13:31
Are there any side effects?For example do you have to wear a glove when applying the gel to stop your fingers from stiffening up?
kop202
05/7/2019
07:46
When one realises that Eli Lilly paid $2.3 billion for the remaining 50% of Cialis maker Icos,on top of an upfront payment of $75 million after only stage 2 trials,Futura's potential becomes obvious. Futura have hugely disruptive products here. A topical ED gel that beats the pants off the competition in efficacy,speed and safety. Topical pains gels that work up to 10 x faster than currently available products. The $90 million expected in upfront and milestones alone covers the market cap. Then 15% royalties will generate huge recurring revenues. Billion dollar opportunity here
j777j
04/7/2019
17:44
Why the sudden drop today?
huntie2
04/7/2019
15:32
The point of a trial is, surely, that you don't get news until it's complete and the results fully analysed. Meantime the excitement of rubbing one's member with gel is bound to produce a few false positives in the interim, one would have thought.
glavey
04/7/2019
14:50
good or bad
glasgow13
04/7/2019
13:58
Almost 100% upside on Liberum's current fair value at 60p. The upside is 140/280p. News can come anytime.
j777j
04/7/2019
13:43
thats the name of the game - you pays your money and makes your choice ;-)
ragnarr
04/7/2019
13:38
And this pot of gold... Sure thing is it?!
5oletrader
04/7/2019
13:33
too many long term holders here because of the pot of gold at the end - imo will settle 35/40 for a bit
ragnarr
04/7/2019
13:27
Up over 600% in 6 months - Think about it
5oletrader
04/7/2019
12:25
Struggling to break 40p and looks like styling here for a bit
ragnarr
04/7/2019
11:40
"What an opportunity that was" Clearly not many thought so at the time. Placing ended up on Primary Bid and Open Offer uptake circa just 25%. Makes you wonder why so many apparently got it all so wrong, doesn't it?
glavey
04/7/2019
09:36
FUM share price is very strong in last few days , i think FUM got some term sheet(s) so a Deal or even Takeover to be closed quickly after Phase 3 readout if successful . £1+ before year end If everything goes well .STROOOOOOONG BUY
bioking
04/7/2019
09:13
ohh... if everything goes to plan over the next few years that forecast will be VERY conservative :-)
ragnarr
04/7/2019
08:48
Each med dose cost 25 cents. Each med dose $5 retail x number of doses each man takes a year = big numbers. "Most of today's licensing agreements are based on the payment of a royalty to the licensor by the licensee. The royalty is a percentage based on a sales price of the goods (the wholesale price if the product is sold at wholesale and the retail price if it is sold at retail.)" According to the last report by Singer,Futura is expected to get a 15% royalty rate. That is on top of $90 million in upfront and milestone payments. Liberum's 140p forecast could yet look rather conservative.
j777j
03/7/2019
15:41
300 million men worldwide and counting.
j777j
03/7/2019
15:30
Up to half of men under 50 suffer from erectile dysfunction, research claims https://www.independent.co.uk/news/health/erectile-dysfunction-impotence-rates-viagra-causes-heart-disease-research-a8985216.html
keifer derrin
03/7/2019
13:31
note to self - spell check!
ragnarr
03/7/2019
13:30
I think we ate past the stage of gamble - even if Med2005 doesnt come off (although looking increasingly unlikely) there is still TPR100 that has been submitted for marketing approval.Ss a very regular user of Volterol due to a chronic back condition the option of a faster reacting gell with a larger dose of diclofenic (1.16% vs 1.86%) is an absolute no btainer The Global market for this type of pain relaif (NAISDs) is 2.9 billion USD.
ragnarr
03/7/2019
11:54
"Thats why Investors should never invest in early stage pharma stock ony in those who have already phase 3 programs ongoing and are close to clinical results if you like to make money." What a nonsense. Without early stage investors there wouldn't be any Phase III programs to back
markacus
Chat Pages: Latest  690  689  688  687  686  685  684  683  682  681  680  679  Older
Your Recent History
LSE
FUM
Futura Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191115 20:28:18